Cargando…
The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer
Breast cancer is the most common cancer in women worldwide with increasing incidence. Significant therapeutics advances in the field of breast cancer have resulted in a growing number of treatment options, whereas de novo or acquired resistance is still a persistent clinical challenge. Drug resistan...
Autores principales: | Yong, Liyun, Tang, Shasha, Yu, Haixin, Zhang, Hongyi, Zhang, Yi, Wan, Yuan, Cai, Fengfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393754/ https://www.ncbi.nlm.nih.gov/pubmed/36003773 http://dx.doi.org/10.3389/fonc.2022.964934 |
Ejemplares similares
-
Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
por: Tang, Shasha, et al.
Publicado: (2023) -
Hypoxia in Breast Cancer—Scientific Translation to Therapeutic and Diagnostic Clinical Applications
por: Zhang, Ying, et al.
Publicado: (2021) -
Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer
por: Zhang, Hongyi, et al.
Publicado: (2021) -
Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
por: Zhang, Hongyi, et al.
Publicado: (2022) -
CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer
por: Tang, Shasha, et al.
Publicado: (2022)